Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the disease free survival and the overall survival
in patients with acute leukemia in first or second complete remission after administrating a
CXCR4 antagonist, as a chemo sensitization strategy, plus chemotherapy as the conditioning
regimen for autologous or allogeneic hematopoietic stem cell transplantation (HSCT).
Phase:
Phase 2
Details
Lead Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran